Metronidazole Impurity 17

Determination and characterization of metronidazole–kaolin interaction
Fadilah Sfouq Aleanizy a, *, Fulwah Alqahtani a , Omaimah Al Gohary a , Eram El Tahir a , Rania Al Shalabi
Saudi Pharmaceutical Journal Volume 23, Issue 2, April 2015, Pages 167-176
 
Adsorption of metronidazole antibiotic using a new magnetic nanocomposite from simulated wastewater (isotherm, kinetic and thermodynamic studies)
Negin Nasseh, Behnam Barikbin, Lobat Taghavi, Mohammad Ali Nasseri
Composites Part B: Engineering Volume 159, 15 February 2019, Pages 146-156
 
Development and validation of liquid chromatographic method for metronidazole
Nandini R. Pai* and Deeptaunshu Atul Pusalkar
Der Pharmacia Sinica, 2014, 5(1):23-28
 
Degradation Study of Metronidazole in Active and Different Formulation by UV Spectroscopy
Safila Naveed*, Nimra Waheed and Safeena Nazeer
Journal of J Bioequivalence & Bioavailability Volume 6(4): 124-127 (2014)
 
A stability indicating hplc method for the determination of metronidazole using ecofriendly solvent as mobile phase component
pratibha verma1 *, varsha namboodiry1, soni mishra1, ashok bhagwat2, suvarna bhoir
Int J Pharm Pharm Sci, Vol 5, Suppl 2, 496-501

Metronidazole Impurity 17 is chemically 1-Methyl-4-nitro-1H-imidazole. Metronidazole Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Metronidazole Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Metronidazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.